I am surprised that ACU has not been able to trade at higher levels.
Credentials of all involved at the Research Institute are very good. We have to remember that it was the institute that developed the new test, not ACU.
Unfortunately another company, Visiomed, which also has an association with the same institute has not been a good market performer recently.
Research takes such a long time and is very expensive with no guarantee of success.
There could be a worry among shareholders and potential investors that the company may need to raise more money to fund this alliance.
No financial details of the agreement have been given as far as I know, and, until they are, I prefer to sit on the sidelines.
- Forums
- ASX - By Stock
- PC1
- any good?
any good?, page-2
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PC1 (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online